Comparison of early events during infection of human and chimpanzeeperipheral blood mononuclear cells with HIV-1

[1]  R. B. Swenson,et al.  Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 , 1997, Journal of virology.

[2]  M. Vesanen,et al.  Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons , 1996, Journal of virology.

[3]  J. Mannhalter,et al.  Quantitative multiple competitive PCR of HIV-1 DNA in a single reaction tube. , 1996, BioTechniques.

[4]  J. Heeney,et al.  Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. , 1996, Immunology letters.

[5]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[6]  J. Heeney.  Primate models for AIDS vaccine development , 1996, AIDS.

[7]  M. Peeters,et al.  Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. , 1995, The Journal of infectious diseases.

[8]  L. Karageorgos,et al.  Stepwise analysis of reverse transcription in a cell-to-cell human immunodeficiency virus infection model: kinetics and implications. , 1995, The Journal of general virology.

[9]  H. Lane,et al.  Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo , 1995, Journal of virology.

[10]  M. Peeters,et al.  Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination. , 1995, The Journal of general virology.

[11]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[12]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[13]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[14]  D. Boldt‐Houle,et al.  The T‐cell receptor Vβ repertoire in naive and human immunodeficiency virus‐1 (HIV‐1) infected chimpanzees , 1994, Journal of medical primatology.

[15]  L. Arthur,et al.  Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. , 1994, Journal of acquired immune deficiency syndromes.

[16]  H. Schuitemaker,et al.  Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants. , 1993, The Journal of infectious diseases.

[17]  P. Fultz.  Nonhuman primate models for AIDS. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  M. Bukrinsky,et al.  Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Arthur,et al.  The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees. , 1993, AIDS research and human retroviruses.

[20]  J. Mannhalter,et al.  CD3, CD8 double-positive cells from HIV-1-infected chimpanzees show group-specific inhibition of HIV-1 replication. , 1993, AIDS research and human retroviruses.

[21]  A. Di Rienzo,et al.  The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. , 1993, Journal of medical primatology.

[22]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[23]  N. Letvin,et al.  A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease , 1991, Journal of virology.

[24]  R. B. Swenson,et al.  Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. , 1991, The Journal of infectious diseases.

[25]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[26]  G. Gaudernack,et al.  CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. , 1990, Journal of immunology.

[27]  J. Levy,et al.  A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. , 1989, Immunology.

[28]  M. Skinner,et al.  Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines , 1988, The Journal of experimental medicine.

[29]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[30]  J. Lifson,et al.  Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. , 1993, BioTechniques.

[31]  J. Levy,et al.  Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. , 1991, Cellular immunology.

[32]  P. Nara,et al.  The Biology of Human Immunodeficiency Virus‐1 IIIB Infection in the Chimpanzee: In Vivo and In Vitro Correlations , 1989, Journal of medical primatology.

[33]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .